⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21895619 | 0.75 | — | — | |
| SCHEMBL25021821 | 0.74 | — | — | |
| SCHEMBL21895575 | 0.71 | — | — | |
| SCHEMBL21846275 | 0.71 | — | — | |
| SCHEMBL21846436 | 0.71 | KRAS (0.35) | — | |
| SCHEMBL21896266 | 0.71 | — | — | |
| SCHEMBL22087305 | 0.70 | — | — | |
| SCHEMBL21895594 | 0.69 | — | — | |
| SCHEMBL21895564 | 0.69 | — | — | |
| SCHEMBL21846220 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3710439-B1 | KRAS G12C INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2023-02-15 | — | — | EP | disclosed |